27-11-2017 PRESS RELEASE

ARCEDI BIOTECH TO PRESENT AT FIFTH ANNUAL ADVANCES IN PRENATAL MOLECULAR DIAGNOSTICS CONFERENCE – Additional Presentations and Panel Discussions Highlight Advances in Cell-Based Non-Invasive Prenatal Testing – Vejle, Denmark, November 27, 2017 – ARCEDI Biotech ApS, a company developing technologies for rare fetal cell detection for use in prenatal diagnostic applications, today announced that Ripudaman […]

read more

13-11-2017 PRESS RELEASE

ARCEDI BIOTECH ANNOUNCES LAUNCH OF FIRST AND ONLY NON-INVASIVE PRENATAL TESTING BASED ON FETAL CELLS IN MATERAL BLOOD IN DENMARK – Comparative Non-Invasive Alternative to Invasive “Gold-Standard” Testing – Vejle, Denmark, November 13, 2017 – ARCEDI Biotech ApS, a company developing technologies for rare fetal cell detection for use in prenatal diagnostic applications, today announced […]

read more

6-11-17 PRESSEMEDDELELSE (Dansk)

PRESSEMEDDELELSE Ny og lovende fosterdiagnostik er mere skånsom for gravide I fremtiden vil det måske blive muligt for gravide at undgå en moderkageprøve. En simpel blodprøve vil kunne give den samme detaljerede viden om fosteret. Det viser ny forskning fra Aarhus Universitetshospital og det danske firma Arcedi Biotech. Mange gravide bliver bekymrede, hvis de får […]

read more

12-10-17 PRESS RELEASE

ARCEDI BIOTECH ANNOUNCES PUBLICATION HIGHLIGHTING SUCCESS OF CUTTING-EDGE CELL-BASED NONINVASIVE PRENATAL TESTING TO DETECT ANEUPLOIDY AND SUBCHROMOSOMAL ABNORMALITIES IN FIRST TRIMESTER PREGNANCIES – Preliminary Results Identical to Invasive “Gold-Standard” Testing – Vejle, Denmark, October 12, 2017 – ARCEDI Biotech ApS, a company developing technologies for rare fetal cell detection for use in prenatal diagnostic applications, […]

read more

10-07-17 PRESS RELEASE

ARCEDI BIOTECH PUBLISHES ARTICLE HIGHLIGHTING ADVANCEMENTS AND POTENTIAL OF CELL-BASED NONINVASIVE PRENATAL TESTING TO DETERMINE PROBABILITY OF FETAL ABNORMALITIES – Company’s Technology Isolates Fetal Cells from Maternal Blood Samples Allowing for Whole Genome Amplification – Vejle, Denmark, July 10, 2017 – ARCEDI Biotech ApS, a company developing technologies for rare cell detection for use in […]

read more